Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate

    NEXT STORY
    Bone Therapeutics announces results of Annual General Meeting
    PREV STORY
    Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Germain Dermatology Adds Image-Guided Superficial Radiotherapy with the SRT-100 Vision™ for Treating Basal and Squamous Cell Carcinoma in Charleston, SC

    author_avatar
    NASDAQ Market News

    Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results

    author_avatar
    NASDAQ Market News

    Claus Frisenberg Pedersen, CCO i Oncology Venture köper aktier i bolaget

    Pressmeddelande Claus Frisenberg Pedersen, CCO i Oncology Venture köper aktier i bolaget Hørsholm, Denmark ...

    author_avatar
    NASDAQ Market News